articleTop 10% cited
Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 Patients
Gynecologic Oncology · 1998 · Vol. 71(3) · pp. 431–436
Ignace Vergote✉(KU Leuven)Ivo De Wever(KU Leuven)Wiebren Tjalma(KU Leuven)M. Van Gramberen(KU Leuven)Jan Decloedt(KU Leuven)Peter van Dam(KU Leuven)
Ovarian cancer diagnosis and treatmentIntraperitoneal and Appendiceal MalignanciesEndometriosis Research and TreatmentMedicineDebulkingSurgeryChemotherapyOvarian carcinomaRetrospective cohort studyStage (stratigraphy)LaparoscopyPrimary tumorOvarian cancer
MeSH terms
AdultAgedAged, 80 and overFemaleHumansMiddle AgedNeoplasm MetastasisNeoplasm StagingOvarian NeoplasmsRetrospective StudiesSurvival RateChemotherapy, Adjuvant
Citations
391
FWCI
9.74
field-weighted impact
References
22
Percentile
98%
vs. same field & year
Citations per year
Cited by
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
Gynecologic Oncology · 2009 · 590 citations
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis
Gynecologic Oncology · 2006 · 398 citations
A Laparoscopy-Based Score To Predict Surgical Outcome in Patients With Advanced Ovarian Carcinoma: A Pilot Study
Annals of Surgical Oncology · 2006 · 394 citations
References
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group study
Gynecologic Oncology · 1992 · 553 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.